[go: up one dir, main page]

WO2016013949A3 - Biomimetic gellable colloid for encoding, processing and sectioning histological samples - Google Patents

Biomimetic gellable colloid for encoding, processing and sectioning histological samples Download PDF

Info

Publication number
WO2016013949A3
WO2016013949A3 PCT/RO2015/000003 RO2015000003W WO2016013949A3 WO 2016013949 A3 WO2016013949 A3 WO 2016013949A3 RO 2015000003 W RO2015000003 W RO 2015000003W WO 2016013949 A3 WO2016013949 A3 WO 2016013949A3
Authority
WO
WIPO (PCT)
Prior art keywords
colloid
sectionable
gellable
sectioning
processing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/RO2015/000003
Other languages
French (fr)
Other versions
WO2016013949A2 (en
Inventor
Sorin Musat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Florea Ileana Maria
Musat Daniela
Original Assignee
Florea Ileana Maria
Musat Daniela
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Florea Ileana Maria, Musat Daniela filed Critical Florea Ileana Maria
Publication of WO2016013949A2 publication Critical patent/WO2016013949A2/en
Publication of WO2016013949A3 publication Critical patent/WO2016013949A3/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/02Devices for withdrawing samples
    • G01N1/04Devices for withdrawing samples in the solid state, e.g. by cutting
    • G01N1/06Devices for withdrawing samples in the solid state, e.g. by cutting providing a thin slice, e.g. microtome
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/36Embedding or analogous mounting of samples
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N1/00Sampling; Preparing specimens for investigation
    • G01N1/28Preparing specimens for investigation including physical details of (bio-)chemical methods covered elsewhere, e.g. G01N33/50, C12Q
    • G01N1/30Staining; Impregnating ; Fixation; Dehydration; Multistep processes for preparing samples of tissue, cell or nucleic acid material and the like for analysis

Landscapes

  • Physics & Mathematics (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Sampling And Sample Adjustment (AREA)

Abstract

The present invention refers to a biomimetic gellable colloid with customizable composition which may be used as a sectionable support for encoding, processing and microtome sectioning of histological specimens for diagnostic examination. The gellable colloid has a uniformly dispersed phase, it comprises a hydrophilic component and may be gelled upon demand. The colloid may be a nanocolloid or a microcolloid. It may also optionally comprise a hydrophobic component. The hydrophilic component comprises at least a protein component and/or a polymerizable carbohydrate and/or a pre- polymerized carbohydrate, in an aqueous phase. The invention also refers to a process for preparing said gellable colloid, a sectionable matrix configured to handle processing and sectioning of histological samples obtained from said gellable colloid, methods for preparing such a sectionable matrix. The invention also discloses a sectionable code for unambiguous and irreversible identification of histological preparations and the use of a gellable colloid to obtain such a sectionable code.
PCT/RO2015/000003 2014-01-28 2015-01-28 Biomimetic gellable colloid for encoding, processing and sectioning histological samples Ceased WO2016013949A2 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
ROA201400075 2014-01-28
RO201400075 2014-01-28
ROA201400078 2014-01-29
RO201400078 2014-01-29

Publications (2)

Publication Number Publication Date
WO2016013949A2 WO2016013949A2 (en) 2016-01-28
WO2016013949A3 true WO2016013949A3 (en) 2016-05-12

Family

ID=55073086

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/RO2015/000003 Ceased WO2016013949A2 (en) 2014-01-28 2015-01-28 Biomimetic gellable colloid for encoding, processing and sectioning histological samples

Country Status (1)

Country Link
WO (1) WO2016013949A2 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3052203A1 (en) 2017-02-09 2018-08-16 Leavitt Medical, Inc. Systems and methods for tissue sample processing
US11129790B2 (en) 2017-05-19 2021-09-28 Northeastern University Chemo-enzymatic site-specific modification of peptides and proteins to form cleavable conjugates
WO2023081329A1 (en) * 2021-11-04 2023-05-11 The Trustees Of Princeton University 3d-printing engineered living materials
WO2025072287A1 (en) * 2023-09-29 2025-04-03 Emit Imaging, Inc. Composition and method of embedding tissue samples

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800457A (en) * 1953-06-30 1957-07-23 Ncr Co Oil-containing microscopic capsules and method of making them
US3405071A (en) * 1963-12-30 1968-10-08 Ibm Process of making microcapsules
WO2005089564A1 (en) * 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
WO2013002661A1 (en) * 2011-06-29 2013-01-03 Musat-Marcu Sorin Matrix for receiving a tissue sample and use thereof

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2800457A (en) * 1953-06-30 1957-07-23 Ncr Co Oil-containing microscopic capsules and method of making them
US3405071A (en) * 1963-12-30 1968-10-08 Ibm Process of making microcapsules
WO2005089564A1 (en) * 2004-03-19 2005-09-29 Danisco A/S Emulsifier composition for shortening
WO2013002661A1 (en) * 2011-06-29 2013-01-03 Musat-Marcu Sorin Matrix for receiving a tissue sample and use thereof

Also Published As

Publication number Publication date
WO2016013949A2 (en) 2016-01-28

Similar Documents

Publication Publication Date Title
WO2018085599A3 (en) Methods of nucleic acid sample preparation for immune repertoire sequencing
EP4545649A3 (en) Methods for processing nucleic acid samples
EP4488383A3 (en) Methods for assessing risk using total and specific cell-free dna
WO2017214338A8 (en) Methods and devices for storing or stabilizing molecules
EP4353830A3 (en) Methods of nucleic acid sample preparation for analysis of cell-free dna
WO2016105508A3 (en) Devices and methods for autonomous measurements
WO2016063068A3 (en) Method and apparatus for the analysis of compounds
WO2016130868A3 (en) Materials and methods to analyze rna isoforms in transcriptomes
GB2569252A (en) Methods of combining the detection of biomolecules into a single assay using fluorescent in situ sequencing
CA2993463C (en) SPATIAL MAPPING OF NUCLEIC ACID SEQUENCE INFORMATION
EP4272860A3 (en) Sample processing device comprising magnetic and mechanical actuating elements using linear or rotational motion
WO2015195949A3 (en) Methods, compositions, and devices for rapid analysis of biological markers
IL247662A0 (en) Composition and method for stabilizing nucleic acids in biological samples
WO2016013949A3 (en) Biomimetic gellable colloid for encoding, processing and sectioning histological samples
WO2015195769A3 (en) Optogenetic probes for measuring membrane potential
WO2016004233A3 (en) Srm assays to chemotherapy targets
WO2015196141A8 (en) Nucleic acid sample preparation
WO2016127077A3 (en) Systems and methods for detection and analysis of biological species
WO2015164991A3 (en) System and method for determining the concentration of solutes in a coloured liquid sample
WO2016191424A3 (en) Novel heteroaromatic silicon-fluoride-acceptors useful for 18f labeling of molecules and biomolecules, and methods of preparing same
EP4249938A3 (en) Method and device for tracking objects, in particular moving objects, in the three-dimensional space of imaging radar sensors
EP3415158A3 (en) Repeat variable diresidues for targeting nucleotides
EP3536805A3 (en) Analytical methods and arrays for use in the same
JP2015057591A5 (en)
EP4300101A3 (en) Antigenic peptides and uses thereof for diagnosing and treating autism

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE

REEP Request for entry into the european phase

Ref document number: 2015820903

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2015820903

Country of ref document: EP

121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 15820903

Country of ref document: EP

Kind code of ref document: A2

122 Ep: pct application non-entry in european phase

Ref document number: 15820903

Country of ref document: EP

Kind code of ref document: A2